Trial Profile
Systemic hypotension following intravenous administration of contrast medium during computed tomography.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Iodixanol (Primary) ; Iopromide
- Indications Hepatic tumours
- Focus Adverse reactions
- 24 Oct 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 12 Nov 2014 New trial record